Re: I wonder what the other 4 are? Plus a new MyoAAV benefit...?
In the meantime, given the MyoAAV for DMD pans out in the trials, we will have that period of time to be judging how Roche is doing with their end of the bargain - selling 9001 worldwide for us. If we like that, then we'd probably prefer they partner with us again for the Myo.
(But we'd have other suitors, I think!)